Seach Medical Group

Seach Medical Group Ltd. is an Israeli public company engaged in the licensed cultivation and supply of medical cannabis under the supervision of the Israeli Ministry of Health. The company has been operating since 2008 and is controlled by its founders, the Sarid family. It focuses on breeding and growing Pharma Grade cannabis strains and supplying them to patients on a monthly basis, as well as research and development of new cannabis-based products. The company was founded in 2002 following the cancer illness of Yehuda (Yuli), the father of the Sarid family. The name 'Seach' derives from the Hebrew acronym of Shai, Yogev, and Hana, and also has an agricultural connotation. In 2005, the company received a first principle license from Dr. Yehuda Baruch, then head of the Medical Cannabis Unit at the Ministry of Health, to grow and sell medical cannabis to licensed patients. In 2008, it began regular distribution of medical cannabis to patients in Israel. In 2010, the Ministry of Health regulated medical cannabis, allowing the company to supply products for a fixed monthly fee of 360 NIS, regardless of product type or quantity. Following regulation, the Sarid family converted their flower greenhouses for export into cannabis greenhouses. In 2019, Seach merged with the shell company Beyond Time Holdings Ltd., which was traded on the Tel Aviv Stock Exchange, making Seach a public company. The company's founders, Shai Abraham Sarid, Yogev Sarid, Ofir Sarid, and Hana Sarid, hold 63.23% of its shares. Seach Medical Group operates through several subsidiaries, including Ivana Technologies Ltd., which focuses on mapping and isolating rare compounds in the cannabis plant and studying their synergy (the 'entourage effect') to develop next-generation personalized cannabis products; Trichomeshel Ltd., which develops innovative consumption products and methods for both medical and recreational markets, and raised 3 million NIS via the PipelBiz crowdfunding platform in late 2020 to establish US production and market CBD in the US and Europe; and Targin Advanced Agriculture Ltd., founded in 2017, which develops advanced growing methods including liquid media (bioreactor) cultivation of plant cells for cannabinoid production and performs strain breeding using genetic editing and marker technologies. The company markets its own house brands, including MV-PARKER, ZYRA, and TAROON, produced under GMP standards. It also operates a network of pharmacies and continues to expand its patient services and product offerings.

Seach Medical Group was founded in 2002 following the cancer illness of Yehuda (Yuli), the father of the Sarid family. The company's name is an acronym of Shai, Yogev, and Hana, and also carries an agricultural association. In 2005, the company received a first principle license from Dr. Yehuda Baruch, then head of the Medical Cannabis Unit at the Ministry of Health, to grow and sell medical cannabis to patients licensed by the Ministry of Health. In 2008, the company began regular distribution of medical cannabis to patients in Israel. In 2010, the Ministry of Health implemented regulation of medical cannabis, allowing the company to supply medical cannabis products to patients for a fixed monthly fee of 360 NIS, regardless of product type or quantity. Following this regulation, the Sarid family, who had previously grown ornamental flowers for export, converted their flower greenhouses into cannabis greenhouses. In 2019, Seach merged with the shell company Beyond Time Holdings Ltd., which was traded on the Tel Aviv Stock Exchange, becoming a public company. The company is controlled by its founders, Shai Abraham Sarid, Yogev Sarid, Ofir Sarid, and Hana Sarid, who together hold 63.23% of the shares. The company operates through subsidiaries including Ivana Technologies Ltd., which focuses on mapping and isolating rare compounds in the cannabis plant and studying their synergy (the 'entourage effect') to develop next-generation personalized cannabis products; Trichomeshel Ltd., which develops innovative consumption products and methods for both medical and recreational markets, and raised 3 million NIS via the PipelBiz crowdfunding platform in late 2020 to establish US production and market CBD in the US and Europe; and Targin Advanced Agriculture Ltd., founded in 2017, which develops advanced growing methods including liquid media (bioreactor) cultivation of plant cells for cannabinoid production and performs strain breeding using genetic editing and marker technologies.

• 2020

  Subsidiary Trichomeshel raised 3 million NIS via PipelBiz crowdfunding.

• 2019

  Merged with shell company Beyond Time Holdings Ltd. on the Tel Aviv Stock Exchange.

• 2017

  Subsidiary Targin Advanced Agriculture Ltd. founded.

• 2010

  Ministry of Health regulation allowed supply for a fixed monthly fee of 360 NIS.

• 2008

  Began regular distribution of medical cannabis to patients in Israel.

• 2005

  Received first principle license from Dr. Yehuda Baruch to grow and sell medical cannabis.

• 2002

  Company founded following the cancer illness of Yehuda (Yuli) Sarid.

Leading provider of advanced medical cannabis treatment solutions in Israel.

• MV-PARKER

  Cannabis strain with genetic source Biscotti X Jealousy X Sherb Bx.

• ZYRA

  Cannabis strain with genetic source Zebra stripes.

• TAROON

  Cannabis strain with genetic source Jokerz #31 | Banana Cream Pop #13.

1. 1Official website homepageseach.co.il
2. 2About pageseach.co.il
3. 3Products pageseach.co.il
4. 4Team pageseach.co.il
5. 5Wikidatawikidata.org
6. 6Hebrew Wikipediahe.wikipedia.org